[144] Eos Energy Enterprises, Inc. SEC Filing

Rhea-AI Filing Summary

Eos Energy Enterprises, Inc. (EOSE) – Form 144 filing discloses a proposed insider sale of common stock.

• Seller & broker: 47,254 common shares are to be sold for the account of Nathan Kroeker through UBS Financial Services Inc., Eleven Madison Ave., New York.
• Transaction size: Aggregate market value is $243,358.10, representing roughly 0.02 % of the 227,589,833 shares outstanding.
• Planned timing & venue: Sale is targeted for 07 / 08 / 2025 on the Nasdaq.
• Source of shares: Shares derive from RSU vesting on 07 / 05 / 2025; 47,254 units vested on that date.
• Recent selling activity: Over the last three months Kroeker sold 152,856 shares on 05 / 16 / 2025 for $1,048,853 and 24,124 shares on 07 / 07 / 2025 for $125,801.84.

The filing is a notice only; execution depends on market conditions, and Rule 144 limits apply. The volume is immaterial versus total shares, but the continued disposition may be monitored by investors assessing insider sentiment.

Positive

• Minimal dilution risk: 47,254 shares represent only 0.02 % of outstanding stock.
• Regulatory transparency: Timely Form 144 filing signals compliance with SEC disclosure requirements.

Negative

• Continued insider selling: 224k shares sold/registered within three months may be viewed as a bearish sentiment indicator.
• Lack of context: Filing provides no information on company performance or a 10b5-1 plan, leaving motives open to interpretation.

Insights

Securities Analyst

TL;DR: Small Rule 144 sale (47k) by insider; negligible dilution, mildly negative signal.

The proposed sale equals just 0.02 % of shares outstanding, so supply impact is de minimis. However, it continues a pattern of insider monetisation—roughly 224k shares disposed over three months for $1.4 million. While Rule 144 filings are routine, clustering of sales can be interpreted as a weak confidence signal. No operational metrics are disclosed, so valuation impact is limited to perception. Overall I classify the filing as neutral-to-slightly negative given its small scale.

Corporate Governance Expert

TL;DR: Routine compliance filing; transparency positive, insider selling optics mixed.

Form 144 demonstrates adherence to securities rules and likely ties to RSU vesting, indicating normal compensation realisation. Public disclosure via EDGAR enhances governance transparency. Still, serial sales within 90 days can draw scrutiny from investors focused on alignment of interests. Absence of a disclosed 10b5-1 plan leaves motives opaque. From a governance standpoint, the event is not materially impactful, but monitoring future filings is prudent.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. Eleven Madison Avenue 4th Floor New York NY 10010	47254	243358.10	227589833	07/08/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/05/2025	RSU Vesting	Issuer			47254	07/05/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Nathan Kroeker 3920 Park Avenue Edison NJ 08820	Common	05/16/2025	152856	1048853.00
Nathan Kroeker 3920 Park Avenue Edison NJ 08820	Common	07/07/2025	24124	125801.84

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many EOSE shares are being registered for sale?

The Form 144 covers 47,254 common shares.

What is the estimated market value of the planned EOSE sale?

The aggregate market value is $243,358.10.

When is the planned sale date for the EOSE shares?

The filer lists an approximate sale date of 07/08/2025.

Which broker will handle the EOSE share sale?

Shares are to be sold through UBS Financial Services Inc. in New York.

What insider selling activity occurred in the past 3 months?

152,856 shares were sold on 05/16/2025 for $1,048,853, and 24,124 shares on 07/07/2025 for $125,801.84.

What is the source of the shares being sold under this Form 144?

The shares resulted from RSU vesting on 07/05/2025.